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One-year trajectories of mental and physical
functioning during and after rehabilitation among
individuals with disabilities
Line Preede1*, Martin Saebu2, Paul. B. Perrin3, Astrid Nyquist2, Haakon Dalen2, Erik Bautz-Holter1,2 and Cecilie Røe1,4
Abstract
Purpose: First, to evaluate the trajectories of physical and mental functioning in individuals with chronic disabilities
receiving adapted physical activity-based rehabilitation. Second, to determine whether demographic factors, disability
group, pain, fatigue and self-efficacy at baseline influenced these trajectories.
Research design: A prospective intervention study.
Methods: The study included 214 subjects with chronic disabilities who were admitted to a four-week adapted physical
activity-based rehabilitation stay at Beitostølen Healthsports Centre. The subjects completed written questionnaires eight
and four weeks before the rehabilitation, at admission to and discharge from the rehabilitation centre and again four
weeks and 12 months after discharge. Multilevel models were performed to examine the trajectories of SF-12 physical
and mental functioning with possible predictors.
Results: Time yielded a statistically significant effect on physical and mental functioning (p < 0.001). Low age (p = 0.002),
no more than 2 h of personal assistance per week (p = 0.023), non-nervous system disability (p = 0.019), low pain
level (p < 0.001) and high chronic disease-efficacy (p = 0.007) were associated with higher physical functioning.
There was a greater improvement in physical functioning for subjects with lower chronic disease-efficacy at baseline
(p = 0.036) and with a disability not associated with the nervous system (p = 0.040). Low fatigue (p = 0.001) and high
chronic disease-efficacy (p = 0.004) predicted higher mental functioning. There was also a greater improvement in mental
functioning for subjects with high fatigue (p =0.003) and low chronic disease efficacy at baseline (p = 0.032).
Conclusion: Individuals with chronic disabilities who participated in an adapted physical activity-based intervention showed
statistically significant increases in both physical and mental functioning across the 12 months after the intervention. The
greatest improvement was among subjects with a high level of fatigue and low chronic disease-efficacy, as well as
disabilities not associated with the nervous system, which has implications for the target groups in future rehabilitation.
Introduction
Chronic disability is generally defined as the conse-
quence of impairment and a difficulty in functioning at
the body, personal, or societal levels in one or more life
domains, as experienced by an individual with a health
condition in interaction with contextual factors [1]. It
may be caused by congenital or acquired diseases or by
trauma and other environmental factors [2]. The burden
of chronic disability is well recognized [3], and the specific
problems vary according to the nature of the impairment.
The World Health Organisation (WHO) has defined
chronic disability to include moderate to severe health loss.
It impacts a person’s well-being and arises from the inter-
action between health conditions and contextual factors,
both personal and environmental [4].
Pain is a subjective experience and the major symptom in
musculoskeletal disorders [5, 6]. Pain is closely associated
with disability and accounts for the largest reduction in
quality of life and functioning [5]. Pain is also a major factor
in neurological conditions [7], but fatigue may contribute
equally to disability in some conditions [8].
Dobkin et al. (2008) defines fatigue as “a subjective lack
of physical and mental energy that interferes with usual
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activity” [9]. It may be caused by the fact that activities of
daily life require most of the individual’s available capacity
[10], which might be quite low because chronic disability is
associated with a reduced physical activity level [11].
Reduced capacity and exercise form a vicious circle
that, together with mobility problems, may result in re-
stricted activities and reduced participation in both
work and leisure activities. Eventually, mental and
physical functioning is affected [12].
The need for rehabilitation is stressed [13]. However,
the effects of rehabilitation on people with disabilities in
general, and particularly over the long term, are seldom
evaluated. As a result, we have little knowledge about
changes and maintenance in functioning over time and
possible effective measures of rehabilitation.
The term “adapted physical activity” refers to physical ac-
tivities adapted to the specific needs of each individual with
a disability [14]. Adapted physical activity-based rehabilita-
tions are based on the adaptation of different activities to fit
each individual’s needs in the rehabilitation setting. These
interventions are in general seldom evaluated, but there are
some studies showing the effects of physical activity and en-
vironmental factors on physical and mental health and
functioning [15–17].
In a previous study conducted at Beitostølen Health-
sports Centre (BHC), both physical and mental functioning
improved during a four-week adapted physical activity-
based rehabilitation [18]. The study lacked long-term follow
up and only assessed the outcome at one time point.
Most of the previous studies on chronic disability and re-
habilitation outcomes have only one time point for follow
up, usually no more than 3 months after discharge from re-
habilitation. This study uses longitudinal trajectories to
examine paths of variables and how they change over a spe-
cific time period. By looking at the trajectories through
multilevel modelling (MLM), predictors of individual path
changes can be identified. To the authors’ knowledge, none
of the previous studies used MLM as recommended for the
analysis of longitudinal data [19].
Thus, the main aim of the present work was to evaluate
the trajectories of physical and mental functioning over one
year in subjects with chronic disabilities who received
adapted physical activity-based rehabilitation. Second, we
wanted to determine whether demographic factors, type of
disability, pain, fatigue and self-efficacy at baseline influ-
enced the trajectories of physical and mental functioning.
Materials and methods
Design
The study design was a prospective intervention study.
Participants and procedures
Subjects with chronic disabilities as defined by WHO, aged
18 years to 73 years (men and woman) and admitted to a
four-week rehabilitation stay at BHC were assessed for
eligibility. Subjects consenting to participating in and
completing the rehabilitation programme were in-
cluded. Written invitations with information about the
study were sent to the participants. Those who ac-
cepted the invitation provided written informed con-
sent. The study was approved by the Regional Medical
Committee for Research Ethics in Norway (S-08837c
2008/21144). All subjects were examined by a medical
doctor upon admission to the rehabilitation centre and
by health professionals according to the subject’s spe-
cific needs. Physiotherapists, nurses, social workers,
and sports rehabilitation specialists comprised the
other professions involved. A team was organized for
each subject. On the second day, the team and the sub-
ject developed a detailed, goal-oriented plan for the
rehabilitation.
Between September 2010 and December 2012, data
were collected by a written questionnaire administered
to the participants eight (baseline) and four weeks be-
fore rehabilitation, at admission to and discharge from
rehabilitation and again at four weeks and twelve
months after discharge (follow-up).
Rehabilitation programme at BHC
The rehabilitation programme at BHC is based on the
vision of adapted physical activity and adapts physical
activities to the needs of the individuals [14].
Goal planning is an essential part of the rehabilitation
process to enhance subject autonomy, treatment adherence,
and feelings of self-efficacy. It provides a basis for individ-
ualized treatments through a structured goal-planning
process. The subject is an active participant in the rehabili-
tation process, and the activity of the rehabilitation team is
goal oriented and takes into account the preferences of the
subject.
The rehabilitation includes social and cultural activities
and extensive use of outdoor natural facilities year round. A
Table 1 Characteristics of the included subjects
Variables n = 214 %
Age (mean) 51.4
Gender Female 119 56
Male 95 44
Living in town/township (>30 000) 120 56
Education (university level) 95 44
Employed 76 36
Personal assistance (>2 h/week) 42 20
Living alone 74 35
Target group Nervous system 102 48
Musculoskeletal 64 30
Others 48 22
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wide range of services is offered, including adaptation of
the environment, technical aids, and individual instruction.
The programme is intensive, with 2 to 5 h of physical activ-
ity a day, six days a week.
Most of the activities are arranged in groups. The
group setting is considered important, encouraging
participants to work together, give feedback to each
other and exchange activity experiences. During their
stay, the participants’ schedules are regularly assessed
and adjusted when necessary. The range of activities
that the rehabilitation centre offers includes swim-
ming, cross-country skiing, alpine skiing, horseback-
riding, aerobics, kayaking and other activities, which
allows each individual to determine the activities best
suited to him or her.
Assessments
Demographic data, including age, gender, education,
residence, employment, and need for personal assistance,
were recorded during an interview with the medical
Table 2 A hierarchical linear model with time, demographic factors, self-efficacy, fatigue and pain as predictors of Medical Outcomes
Study 12-item Short Form Health Survey Physical Functioning Component Summary
Predictor variable b-weight SE df t p-value 95 % Confidence Interval
Lower Upper
Time 0.73 0.10 986.93 7.61 ***0.000 0.54 0.91
Sex 0.16 0.92 213.76 0.17 0.862 −1.65 1.97
Age −0.11 0.04 215.35 −3.16 **0.002 −0.18 −0.04
Employment 2.23 0.98 213.24 2.29 *0.023 0.31 4.16
Living alone 0.03 0.95 214.09 −0.26 0.979 −1.85 1.90
Living in town (>30’) 0.66 0.95 213.31 0.69 0.489 −1.21 2.52
Education 0.10 0.96 212.89 0.10 0.917 −1.79 1.99
Personal assistance (>2 h/week) −2.26 1.16 215.12 −1.95 0.052 −4.54 0.02
Disability 2.17 0.92 214.16 2.35 *0.019 0.35 3.98
Exercise-efficacy 0.40 0.25 214.22 1.63 0.105 −0.01 0.89
Social-efficacy 0.30 0.22 213.31 1.34 0.180 −0.14 0.74
Chronic disease-efficacy 0.90 0.33 215.64 2.74 **0.007 0.25 1.56
Fatigue 0.00 0.02 213.22 −0.01 0.990 −0.03 0.03
Pain −0.09 0.02 214.15 −4.35 ***0.000 −0.13 −0.05
Note. *= p < .05; **= p < .01; ***= p < .001
Fig. 1 Change in Medical Outcomes Study 12-item Short Form
Health Survey Physical Functioning Component Summary (PCS) for
the high and low chronic disease-efficacy groups with
standard error
Fig. 2 Change in Medical Outcomes Study 12-item Short Form
Health Survey Physical Functioning Component Summary (PCS) for
the disability groups with standard error
Preede et al. Health and Quality of Life Outcomes  (2015) 13:135 Page 3 of 11
doctor on admission to the rehabilitation centre. Diag-
noses were obtained from the referral letter for the re-
habilitation stay and were validated by the doctor at
admission. The main reasons for disability were grouped
according to disorders of the nervous system, disorders
of the musculoskeletal system and other disorders.
Perceived physical and mental functioning were mea-
sured by the Medical Outcomes Study 12-item Short Form
Health Survey (SF-12, licence number QM 027126)
[20, 21]. The SF-12 consists of 12 items and yields a
Physical Component Summary and Mental Component
Summary, which are intended to reflect perceived physical
and mental functioning, respectively. The SF-12 has been
shown to capture approximately 90 % of the variance in the
SF-36 and to reflect the same 8 dimensions [20, 21]. The
SF-12 is far less time consuming than the SF-36. It was
regarded by the subjects as easier to complete and was
chosen to increase the response rate after discharge. The
answers were given on a Likert-type scale with 3 or 5 scor-
ing levels for the different items. The Physical and Mental
Component Summary (PCS and MCS) norm-based scores
for the SF-12 were calculated using the reversed scores of
questions 1, 8, 9 and 10 [22]. Mean PCS and MCS for a
Norwegian reference population were used for comparison
of the study population’s mean scores. The reference scores
are 50.3 (SD 8.8) for PCS and 50.6 (SD 9.9) for MCS [20].
The Norwegian versions of three separate scales were
used to capture the different elements of self-efficacy.
Efficacy for managing chronic disease (Chronic disease-
efficacy) was measured by the Self-Efficacy for Managing
Chronic Disease 6-Item Scale [23]. A sample item is as
follows: “How confident are you that you can keep the
fatigue caused by your disease from interfering with
the things you want to do?” Responses were given on a
10-point Likert-type scale ranging from not at all
confident (1) to totally confident (10). The scale has
been shown to be valid in a sample with 489 subjects
with chronic disease and has demonstrated high in-
ternal consistency (0.91).
Efficacy for exercise regularly (Exercise-efficacy) was
measured by the Exercise Regularly Scale (3-item scale)
in the Stanford Chronic Disease Self-Efficacy Scales [24].
A sample item is, “How confident are you that you can
do aerobic exercise such as walking, swimming, or bicyc-
ling three to four times each week?” Responses were
given on a 10-point Likert-type scale ranging from not
at all confident (1) to totally confident (10). The scale
has shown good validity in a sample with 478 subjects
Table 3 A hierarchical linear model with statistically significant predictors from Table 2 and their interactions with time as predictors
of Medical Outcomes Study 12-item Short Form Health Survey Physical Functioning Component Summary
Predictor variable b-weight SE df t p-value 95 % Confidence Interval
Lower Upper
Time 0.67 0.15 987.89 4.40 ***0.000 0.37 0.97
Age −0.11 0.04 339.34 −2.90 **0.004 −0.19 −0.04
Employment 3.67 1.07 335.55 3.43 **0.001 1.57 5.78
Disability 1.05 1.03 338.45 1.01 0.313 −0.99 3.08
Chronic disease-efficacy 1.60 0.30 339.74 5.36 ***0.000 1.01 2.18
Pain −0.10 0.02 339.80 −4.89 ***0.000 −0.14 −0.06
Time *Age 0.00 0.01 989.90 .12 0.906 −0.01 0.02
Time *Employment −0.38 0.20 985.69 −1.91 0.056 −0.77 0.01
Time *Disability 0.40 0.19 987.44 2.06 *0.040 0.02 0.78
Time *Chronic disease-efficacy −0.12 0.06 989.67 −2.10 *0.036 −0.23 −0.01
Time *Pain 0.01 0.00 990.81 1.61 0.107 −0.00 0.01
Note. *= p < .05; **= p < .01; ***= p < .001
Table 4 Change in Medical Outcomes Study 12-item Short Form Health Survey Physical Functioning Component Summary for
subjects with low chronic disease-efficacy
Mean change SD p-value 95 % Confidence Interval
Lower Upper
Baseline – Departure (n = 102) 5.31 7.60 0.000*** 3.82 6.81
Departure – 12 months (n = 86) −2.37 6.85 0.002** −3.84 −0.91
Baseline – 12 months (n = 91) 3.16 7.40 0.000*** 1.62 4.70
Note. *= p < .05; **= p < .01; ***= p < .001
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with chronic disease (the internal consistency was 0.83,
and the test-retest reliability was 0.86).
Efficacy for social/recreational activities (Social-efficacy)
was measured by the Social/Recreational Activities scale
(2-item scale) in the Stanford Chronic Disease Self-Efficacy
Scales [24]. A sample item is, “How confident are you that
you can continue to do your hobbies and recreation?” Re-
sponses were given on a 10-point Likert-type scale ranging
from not at all confident (1) to totally confident (10). The
scale has shown to be valid in a sample with 478 subjects
with chronic disease (the internal consistency was 0.84, and
the test-retest reliability was 0.84).
Pain and fatigue were measured by visual analogue
scales (VAS) 100 mm long on a scale of 0–100 (“no pain”
to “intolerable pain” and, for fatigue, “not a problem” to
“a very big problem”) [25, 26].
Statistical methods
T-test and chi-square statistics were applied to compare
the subjects dropping out with those completing the
study. Multi-level models (MLMs) were performed to
examine whether linear trajectories of the SF-12 physical
and mental scores over one year could be predicted by
time, sex, age, type of disability, education, employment,
personal assistance, pain, fatigue, and self-efficacy. These
variables were all entered simultaneously as fixed effects
into the models. For the purpose of the analysis, the dis-
ability categories were merged into two groups (those
with nervous system disabilities and those with other
disabilities). The respective mean was subtracted from
all variables for the purpose of centring them before be-
ing entered into the MLM. SF-12 scores at each of the
six time points (baseline, four weeks before admission,
at admission to and discharge from rehabilitation, four
weeks after discharge, and 12 months after discharge)
were entered as the dependent variables in each model.
A second set of two MLMs was then run to examine
whether any of the statistically significant fixed effects in
the first two models interacted significantly with time in
the prediction of participants’ physical and mental func-
tioning trajectories, which would indicate that these tra-
jectories changed differentially over time as a function of
one of the predictors.
Predictors with significant interactions with time were
dichotomized around their mean level (high/low), and
paired sample t-tests were also conducted to evaluate
changes from baseline to the 12-month follow up for
subjects with high and low levels of the predictor. All
data were analysed using SPSS, version 21. A signifi-
cance level of 0.05 was adopted.
Results
Participants
From the subjects admitted to rehabilitation, 321 were
assessed for eligibility and 304 were eligible after exclu-
sion. The exclusion criteria were insufficient knowledge
of Norwegian to fill out the questionnaires and severe
cognitive disorders. Of the eligible subjects, 246 subjects
consented to participation and 32 dropped out before or
during the intervention, which resulted in 214 subjects
who completed rehabilitation and were included in the
study. The gender (56 % females) and age (47 years) of
the 32 subjects who dropped out did not differ signifi-
cantly from the subjects included in the data analysis
(Chi square = 0.000,p = 0.985 and F = 2.948, p = 0.087, re-
spectively). There were no significant differences in the dis-
tribution of disability groups between the 32 subjects who
dropped out (50 % nervous system, 31 % musculoskeletal
Table 5 Change in Medical Outcomes Study 12-item Short Form Health Survey Physical Functioning Component Summary for
subjects with high chronic disease-efficacy
Mean change SD p-value 95 % Confidence Interval
Lower Upper
Baseline – Departure (n = 102) 5.31 8.53 0.000*** 3.63 6.98
Departure – 12 months (n = 91) −4.90 7.91 0.000*** −6.54 −3.25
Baseline – 12 months (n = 94) 0.63 8.66 0.484 −1.15 2.40
Note. *= p < .05; **= p < .01; ***= p < .001
Table 6 Change in Medical Outcomes Study 12-item Short Form Health Survey Physical Functioning Component Summary for
subjects with disability not associated with the nervous system
Mean change SD p-value 95 % Confidence Interval
Lower Upper
Baseline – Departure (n = 109) 5.12 8.57 0.000*** 3.50 6.75
Departure – 12 months (n = 91) −3.22 7.93 0.000*** −4.87 −1.57
Baseline – 12 months (n = 94) 2.47 8.50 0.006** 0.73 4.21
Note. *= p < .05; **= p < .01; ***= p < .001
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and 19 % others) and the 214 subjects who completed the
programme (see Table 1) (chi square =0.384, p = 0.944). Re-
ported musculoskeletal problems included rheumatic dis-
eases as the most frequent diagnostic entities. Neurological
problems included cerebral palsy, multiple sclerosis and
inherited motor neuron disorders as the most frequent
diagnostic entities. Cerebrovascular diseases, spinal cord in-
juries and visual impairments were the other reported rea-
sons for disability. The median duration of disease that
caused disability was 18.1 years.
Of the included subjects, 61 did not complete one or
more of the 6 questionnaires. They were still included in
the MLM, which is robust to missing data. Table 1 shows
the characteristics of the included subjects (n = 209).
Trajectory of physical functioning
The physical functioning at baseline was rather low, with
a mean PCS score of 37.38 (SD 9.60). The MLM showed
that physical functioning improved across the six time
points (p < 0.001) (Table 2), with the main improve-
ment being between admission to and discharge from
rehabilitation (Figs. 1 and 2). The mean PCS at dis-
charge was 42.48 (SD 8.16), and at the 12-month fol-
low up, the mean was 39.33 (SD 9.16).
A younger age, employment and disability not associ-
ated with the nervous system predicted better physical
functioning over time (p = 0.002, p = 0.023 and p = 0.019,
respectively). Furthermore, subjects with higher chronic
disease-efficacy (p = 0.007) as well as lower levels of pain
(p < 0.001) also had better physical functioning (Table 2).
There was a statistically significant interaction between
disability and time (p = 0.040) and between chronic
disease-efficacy and time (p = 0.036). The improvement
in physical functioning during and after rehabilitation
was greater in subjects with a disability not associated
with the nervous system and with lower chronic disease-
efficacy at baseline (Table 3). After dichotomizing into
low and high chronic disease-efficacy around the mean
of 6.55, the two groups had the same improvement in
physical functioning from baseline to discharge, but the
subjects with higher self-efficacy had a greater decline
from discharge to the 12-month follow up (Fig. 1). At
Table 7 Change in Medical Outcomes Study 12-item Short Form Health Survey Physical Functioning Component Summary for
subjects with disability associated with the nervous system
Mean change SD p-value 95 % Confidence Interval
Lower Upper
Baseline – Departure (n = 95) 5.53 7.47 0.000*** 4.01 7.05
Departure – 12 months (n = 86) −4.15 7.02 0.000*** −5.66 −2.65
Baseline – 12 months (n = 91) 1.26 7.76 0.126 −0.36 2.87
Note. *= p < .05; **= p < .01; ***= p < .001
Table 8 A hierarchical linear model with time, demographic factors, self-efficacy, fatigue and pain as predictors of Medical Outcomes
Study 12-item Short Form Health Survey Mental Functioning Component Summary
Predictor Variable b-weight SE df t p-value 95 % Confidence Interval
Lower Upper
Time 0.85 0.11 986.06 7.39 ***0.000 0.62 1.07
Sex −1.50 1.00 211.55 −1.50 0.135 −3.46 0.47
Age 0.02 0.04 213.42 0.43 0.671 −0.06 0.09
Employment −0.39 1.06 210.95 −0.37 0.714 −2.49 1.71
Living alone −1.17 1.03 211.95 −1.14 0.257 −3.21 0.86
Living in town (>30’) 0.79 1.03 211.04 0.77 0.443 −1.24 2.82
Education 0.45 1.04 210.54 0.43 0.667 −1.61 2.51
Personal assistance (>2 h/week) 1.91 1.26 213.15 1.52 0.131 −0.57 4.40
Disability −0.73 1.00 212.04 −0.73 0.465 −2.71 1.24
Exercise-efficacy 0.41 0.27 212.12 1.52 0.129 −0.12 0.95
Social-efficacy −0.11 0.24 211.04 −0.44 0.663 −0.59 0.37
Chronic disease-efficacy 1.05 0.36 213.76 2.93 **0.004 0.34 1.76
Fatigue −0.06 0.02 210.94 −3.22 **0.001 −0.09 −0.02
Pain −0.04 0.02 212.04 −1.78 0.077 −0.08 0.00
Note. *= p < .05; **= p < .01; ***= p < .001
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the 12-month follow up, physical functioning signifi-
cantly improved compared to baseline, with a mean of
3.16 (SD 7.40) in the low chronic disease-efficacy group
(p < 0.001) (Table 4). Subjects with high chronic disease-
efficacy at baseline showed no statistically significant im-
provement in physical functioning at the 12-month follow
up (mean change 0.63, SD 8.66, p = 0.484) (Table 5). Paired
comparisons of subjects with or without disabilities associ-
ated with the nervous system also showed a significant
improvement in both groups from baseline to discharge,
but subjects with disabilities not associated with the
nervous system did not show as great a decrease as those
with a nervous system-associated disability (Fig. 2). At the
12-month follow up, physical functioning significantly im-
proved compared to baseline with a mean of 2.47 (SD 8.50)
in the group with disabilities not associated with the
nervous system (p < 0.006) (Table 6). Subjects with ner-
vous system disabilities showed no statistically significant
improvement in physical functioning at the 12-month fol-
low up (mean change 1.26, SD 7.76, p = 0.126) (Table 7).
Trajectory of mental functioning
Subjects’ baseline values of mental functioning showed a
mean MCS score of 49.52 (SD 10.28). The MLM showed
that mental functioning improved across the six time
points (p < 0.001) (Table 8), with the main improvement
being between admission to and discharge from rehabili-
tation (Figs. 3 and 4). The mean MCS at discharge was
56.35 (SD 8.25). At the 12-month follow up, the mean
was 52.40 (SD 10.00).
Subjects with higher chronic disease-efficacy (p = 0.004)
and lower fatigue (p = 0.001) had better mental functioning
over time (Table 8).
There was a statistically significant relationship between
time and chronic disease efficacy (p = 0.032) and between
time and fatigue (p = 0.003). The improvement in mental
functioning during and after rehabilitation was greater in
subjects with low levels of chronic disease-efficacy and high
levels of fatigue (Table 9). Data were dichotomized into
high and low chronic disease-efficacy and fatigue around
the means of 6.55 and 49.37, respectively. The group of
subjects with high levels of fatigue improved their mental
functioning more from baseline to discharge compared to
the low-level group, but the decline after discharge was also
greater (Fig. 3). Despite the decline, subjects with high
levels of fatigue had a significant improvement in mental
functioning from baseline to the 12-month follow up (mean
difference 3.65, SD 8.46, p < 0.001) (Table 10). Subjects with
low levels of fatigue had no statistically significant change
in mental functioning during the same time period
(mean difference 1.29, SD 9.71, p = 0.212) (Table 11).
Subjects with low chronic disease-efficacy at baseline
also improved more in mental functioning from base-
line to discharge from rehabilitation (Fig. 4). Although
they had a slightly greater decline after discharge than
the high chronic disease-efficacy group, subjects with
low chronic disease-efficacy had a significant improvement
in mental functioning from baseline to the 12-month follow
up (mean difference 3.65, SD 9.86, p = 0.001) (Table 12).
Subjects with high chronic disease-efficacy at baseline
showed no statistically significant improvement in mental
functioning at the 12-month follow up (mean difference
1.39, SD 8.30, p = 0.108) (Table 13).
Discussion
The results show that both mental and physical functioning
improved during rehabilitation and that improvement
Fig. 3 Change in Medical Outcomes Study 12-item Short Form
Health Survey Mental Functioning Component Summary (MCS) for
subjects with high and low levels of fatigue with standard error
Fig. 4 Change in Medical Outcomes Study 12-item Short Form
Health Survey Mental Functioning Component Summary (MCS) for
the high and low chronic disease-efficacy groups with
standard error
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remained statistically significant at the 12-month follow up
compared to baseline. This supports previous studies indi-
cating an association between rehabilitation and improve-
ment in mental and physical functioning up to three
months after rehabilitation [18, 27] and provides new
knowledge about the longer-term effects of rehabilitation.
Physical functioning for this sample was low compared to
a Norwegian reference population [20]. Previous studies
have also found a significant reduction in physical function-
ing in populations with chronic diseases [12, 28]. Although
the sample had a significant improvement in physical func-
tioning from baseline to discharge, physical functioning was
still 15 % below the reference population, which is expected
considering the nature of the disability in subjects referred
to rehabilitation at BHC.
The mental functioning was almost in line with the
Norwegian reference population [20]. This is similar to
what has been shown in previous research [29, 30].
During the intervention, mental functioning rose to a
higher level than the reference population. BHC may
be a perfect setting to improve mental functioning for
subjects with disabilities, as it is an environment away
from everyday life struggles, brings together people who
have similar disabilities and health problems, and is guided
by well-trained instructors and health workers.
Mental and physical functioning started to improve
even before admission to the rehabilitation programme.
This might be because of expectations that come from
the subjects looking forward to the programme or be-
cause they engaged in more exercise to start to improve
their functioning before the intervention started. However,
the effects of expectations are mainly studied regarding out-
come of treatment [31].
In the present study, the improvement in mental and
physical functioning from baseline to discharge was
more than twice the reported detectable changes of 3 for
MCS and 2–3 for PCS [32]. Although the SF-12 is a gen-
eric measurement, the clinical significance of changes
may vary across disabilities and be influenced by envir-
onmental factors. Large variations in clinically important
differences have also been reported in the literature
[33–36]. Because of the detected change, the improve-
ment in mental and physical functioning from baseline
to discharge in this study is of high clinical relevance.
With the decline after discharge, the improvements we
found in both mental and physical functioning at the
12-month follow up are just below the levels of clinical
relevance (2.88 and 1.99, respectively).
The results also show, not surprisingly, that subjects with
lower age, those who are employed and those who have dis-
abilities not associated with the nervous system had higher
physical functioning over time. Previous findings support
the importance of young age in rehabilitation [37–39].
Pain, fatigue and self-efficacy at baseline had effects on
the trajectories of physical and mental functioning. Both
higher efficacy for managing chronic disease and lower
pain predict higher physical functioning at each time
point. Higher efficacy for managing chronic disease and
lower fatigue predict higher mental functioning at each
time point. This result supports the findings of previous
Table 9 A hierarchical linear model with statistically significant predictors from Table 6 and their interactions with time as predictors
of Medical Outcomes Study 12-item Short Form Health Survey Mental Functioning Component Summary
Predictor variable b-weight SE df t p-value 95 % Confidence Interval
Lower Upper
Time 0.88 0.11 985.97 7.73 ***0.000 0.66 1.10
Chronic disease-efficacy 1.65 0.33 358.49 4.99 ***0.000 1.00 2.30
Fatigue −0.10 0.02 357.72 −5.09 ***0.000 −0.14 −0.06
Time * Chronic disease-efficacy −0.14 0.07 987.18 −2.15 *0.032 −0.27 −0.01
Time * Fatigue 0.01 0.00 985.18 3.00 **0.003 0.00 0.02
Note. * = p < .05; ** = p < .01; *** = p < .001
Table 10 Change in Medical Outcomes Study 12-item Short Form Health Survey Mental Functioning Component Summary for sub-
jects with high levels of fatigue
Mean change SD p-value 95 % Confidence Interval
Lower Upper
Baseline – Departure (n = 114) 8.69 9.13 0.000*** 7.00 10.39
Departure – 12 months (n = 90) −5.27 7.85 0.000*** −6.91 −3.62
Baseline – 12 months (n = 95) 3.65 8.46 0.000*** 1.93 5.37
Note. *= p < .05; **= p < .01; ***= p < .001
Preede et al. Health and Quality of Life Outcomes  (2015) 13:135 Page 8 of 11
studies that investigated the association between self-
efficacy and functioning [29, 40, 41] and the association
between fatigue and functioning [27, 38].
Subjects with high levels of fatigue at baseline im-
proved their mental functioning, while subjects with low
levels did not have any improvement at the 12-month
follow up. The biggest improvements happened during
the intervention period, where both groups improved.
The high-fatigue group degraded more than the low-fatigue
group after discharge, but they still showed a significant im-
provement at the 12-month follow up. It is interesting that
the intervention specifically improved the long-term mental
functioning of the subjects with high fatigue because it is
well known that fatigue impacts a person’s functioning
[42–44]. This means that even though the high-fatigue
group still had a lower level mental function than the
low-fatigue group, the intervention tended to improve
it long term.
It is interesting that subjects with lower efficacy for
managing chronic disease at baseline had greater im-
provement in both mental and physical functioning
over time than subjects with higher efficacy. This
group started their rehabilitation with many insecur-
ities about managing their disease, which might have
held them back with regard to improvement. After
some time in the BHC environment, it appeared as
though they became more secure and observed that
others could manage the same disease. This improve-
ment in security might last and help them to maintain
their physical and mental functioning after returning
to their home environment. It is also important to note
that the low-efficacy group maintained their physical func-
tioning without degrading too much after returning to their
home environment. This study did not investigate reasons
for the maintenance of functioning after discharge, but it is
likely that the intervention is a factor. Subjects with high
efficacy for managing chronic disease showed no im-
provement at the 12-month follow up, even though
they did improve their mental and physical functioning
during the intervention. The fact that subjects with
low chronic disease-efficacy at baseline had a greater
improvement in functioning was also stated in a previ-
ous study on individuals with neuromuscular diseases
and multiple sclerosis [45], although that study measured
outcome over a shorter time period. These effects could
also be the result of statistical regression to the mean over
time, whereby participants with a low efficacy at baseline
could also be those with the lowest levels of physical
and mental functioning and therefore be the groups
who have the most room for improvement in function-
ing during rehabilitation.
Strengths and limitations
A strength of this study is the use of multi-level model-
ling, which handles time with unequal spacing and is
flexible in handling missing data [19]. This makes it
possible to include subjects who did not complete the
questionnaire at one or more of the six time points and
thereby increases statistical power and improves precision.
Very few studies have evaluated the effects of an adapted
physical activity-based intervention. To our knowledge
Sprott et al. is one of very few studies that has focused on
adapted physical activity for pain patients [46]. Additionally,
a study focusing on the effects of equine-assisted activities
and therapies for children with cerebral palsy exists [47].
This study contributes important knowledge about the ef-
fects of an adapted physical activity-based intervention in a
generalized group of subjects with chronic disabilities.
Table 11 Change in Medical Outcomes Study 12-item Short Form Health Survey Mental Functioning Component Summary for
subjects with low levels of fatigue
Mean change SD p-value 95 % Confidence Interval
Lower Upper
Baseline – Departure (n = 90) 4.35 9.87 0.000*** 2.27 6.40
Departure – 12 months (n = 87) −3.37 8.35 0.000*** −5.15 −1.59
Baseline – 12 months (n = 90) 1.29 9.71 0.212 −0.75 3.32
Note. *= p < .05; **= p < .01; ***= p < .001
Table 12 Change in Medical Outcomes Study 12-item Short Form Health Survey Mental Functioning Component Summary for
subjects with low chronic disease-efficacy
Mean change SD p-value 95 % Confidence Interval
Lower Upper
Baseline – Departure (n = 102) 7.79 10.69 0.000*** 5.69 9.89
Departure – 12 months (n = 86) −4.45 8.31 0.000*** −6.23 −2.66
Baseline – 12 months (n = 91) 3.65 9.86 0.001** 1.60 5.70
Note. *= p < .05; **= p < .01; ***= p < .001
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The data collection at admission and discharge oc-
curred at the rehabilitation facility, while data from all
other time points were collected in the subjects’ home
environment. This might have contributed to bias due to
environmental influence. The benefit of subjects com-
pleting measures at the facility, and thereby making it a
part of the rehabilitation stay, could have decreased the
drop-out rate at these time points.
We cannot exclude the possibility of an improvement in
physical and mental functioning over time without a re-
habilitation stay. However, taking into account that prob-
lems the study population face have had a long duration
and that there was no improvement during the 8 weeks
prior to admission, this improvement seems unlikely. To
further investigate the change of improvement, a control
group is needed. Because the programme must be provided
for those who are in need, it would be ethically challenging
to follow a similar group for 12 months without giving
them the same intervention during that period.
The subjects who attend rehabilitation at BHC might
not fully reflect the Norwegian population with chronic
disabilities. It is, of course, a voluntary decision to par-
ticipate in a rehabilitation stay, and the subjects who
chose it might be more motivated to improve their func-
tional skills and physical capacity, as well as to meet new
people in such an environment. They also have to be able
to leave their everyday environment, family and work situ-
ation for a period of 4 weeks to attend rehabilitation.
We have used the word functioning to describe The
Medical Outcome Studies Short-Form mental and phys-
ical component scores (MCS and PCS). Earlier research
has used terms such as mental and physical health, men-
tal and physical functioning and health-related quality of
life [18, 48, 49]. The ability of this type of instrument to
reflect relevant changes in chronic disabilities has been
debated [50], and it has also been debated whether qual-
ity of life is a good term regarding the content of these
measurements [51]. The present study supports the
feasibility of the SF-12 instrument, at least when viewed
as a measure of functioning.
This study shows how the trajectories of physical and
mental functioning in individuals with disabilities vary over
the course of rehabilitation. An adapted physical activity-
based intervention is associated with improvements in both
physical and mental functioning, and this improvement is
statistically significant 12 months after the intervention. An
important goal of the rehabilitation programme is sustained
long-term improvement. The clinical implication of these
results could be that rehabilitation programmes similar to
the one at BHC can assess participant self-efficacy and help
individuals with disabilities explore the ways in which their
self-efficacy influences their engagement in rehabilitation
and possibly the resulting gains.
Future research should focus on causes of the decrease
in mental and physical functioning after discharge and
on trajectories with a longer follow-up period to look for
further changes in outcomes. Such knowledge could
contribute to improvements in the long-term rehabilita-
tion care for individuals with disabilities.
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